Abstract
PURPOSE. Chemokine receptor 7 (CCR7) is a key homing molecule for immune cell trafficking, including corneal antigenpresenting cell (APC) migration from the inflamed cornea to draining lymph nodes (LNs). Here, the authors investigated the effect of CCR7-facilitated donor APC trafficking on allosensitization, regulatory T-cell (Treg) function, and graft survival in corneal transplantation. METHODS. CCR7-/- or wild-type (WT) allogeneic corneal grafts were transplanted onto the neovascularized high-risk recipient beds. Two weeks later, the frequency of directly alloprimed host T cells was measured by the IFN-γ ELISPOT assay. Treg function was tested by a coculture suppression assay and an IFN-γ ELISPOT assay. Kaplan-Meier analysis was performed to evaluate graft survival. RESULTS. The recipients of CCR7-/- grafts had fewer migrated donor APCs and lower frequency of IFN-γ-producing T cells in the draining LNs. However, there was no statistically significant difference in transplant survival between recipients of CCR7-/- and those of WT grafts. Tregs from the CCR7-/- graft recipient group showed reduced regulatory potential for the suppression of proliferation of naive T cells and direct alloprimed T cells and expressed lower Foxp3 levels. In vitro studies confirmed that mature CCR7+ major histocompatibility complex class II+ CD86+ graft-derived dendritic cells were critical for Treg function. CONCLUSIONS. Not only is CCR7-mediated donor-derived APC trafficking to the draining LNs important in the initiation of host T-cell priming, it is crucial for Treg-mediated tolerance. © Association for Research in Vision and Ophthalmology.
Cite
CITATION STYLE
Jin, Y., Chauhan, S. K., Saban, D. R., & Dana, R. (2010). Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Investigative Ophthalmology and Visual Science, 51(2), 816–821. https://doi.org/10.1167/iovs.09-3952
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.